Hydrokortison Evolan (Hydrocortisone)

Hydrokortison Evolan is employed in dermatology for its anti‑inflammatory and immunosuppressive properties when applied to the skin.

• Management of mild to moderate eczema and atopic dermatitis.
• Relief of symptoms associated with contact dermatitis or allergic skin reactions.
• Treatment of localized psoriasis plaques.
• Soothing of insect bite reactions and minor skin irritations.
• Adjunct therapy for superficial fungal infections to reduce inflammation.

• Hydrokortison Evolan delivers hydrocortisone to the skin, where it diffuses into keratinocytes and immune cells and binds intracellular glucocorticoid receptors. This receptor complex translocates to the nucleus and modulates gene transcription, suppressing pro‑inflammatory cytokine production, inhibiting leukocyte migration, and reducing vascular permeability, thereby producing local anti‑inflammatory and immunosuppressive effects.

Adverse reactions to topical hydrocortisone are generally localized, but systemic effects can occur with extensive or prolonged use.

Common

• Mild burning or stinging at the application site.
• Transient itching or irritation.
• Dryness or flaking of the treated skin.
• Redness (erythema) that resolves after discontinuation.
• Folliculitis or acneiform eruptions.

Serious

• Skin atrophy or thinning with prolonged use.
• Development of telangiectasia (visible small blood vessels).
• Secondary bacterial, fungal, or viral infection of the skin.
• Allergic contact dermatitis to the formulation.
• Systemic adrenal suppression when large areas are treated for extended periods.

When using Hydrokortison Evolan, several safety considerations should be observed to minimize risks.

• Avoid application on broken, infected, or ulcerated skin unless directed by a clinician.
• Limit duration of use; prolonged therapy can increase the risk of skin atrophy.
• Do not cover the treated area with occlusive dressings unless specifically advised.
• Use with caution in pediatric patients, as children are more susceptible to systemic absorption.
• Discuss use during pregnancy or lactation with a healthcare professional, as safety data are limited.
• Monitor for signs of secondary infection and discontinue if infection develops.

Topical hydrocortisone may interact with other dermatologic agents, affecting efficacy or safety.

Avoid

• Concurrent use of other potent topical corticosteroids on the same area, which can increase systemic absorption.
• Application of topical antibiotics or antifungals that may be inactivated by the steroid's anti‑inflammatory action.

Use with caution

• Combining with retinoids or keratolytic agents, which may increase skin irritation.
• Use alongside systemic corticosteroids, as additive immunosuppressive effects may occur.
• Application with photosensitizing drugs, as steroid use can mask early signs of phototoxic reactions.